Literature DB >> 8577311

Correlation of interstitial pneumonia with human cytomegalovirus-induced lung infection and graft-versus-host disease after bone marrow transplantation.

C A Müller1, H Hebart, A Roos, H Roos, M Steidle, H Einsele.   

Abstract

In a retrospective analysis lung biopsy specimens obtained postmortem from 30 consecutive allogeneic bone marrow transplant recipients who had died of either either interstitial pneumonitis (IP; 18/30 patients) or various other causes (12/30 patients) were studied for the local presence of human cytomegalovirus (HCMV) by culture, in situ hybridization, polymerase chain reaction (PCR) and immunohistochemistry for HCMV proteins. All patients suffering from IP were found to be HCMV positive in the lung biopsy. PCR revealed the highest sensitivity for HCMV detection in lung biopsies, but in 15/18 PCR-positive samples local HCMV infection could be confirmed by at least one additional technique. All the lung biopsies obtained from the 12 patients without IP were negative for HCMV by all techniques applied, except one with a weak HCMV-DNA signal in the PCR assay. The severity of the clinical, as well as histological and immunohistological alterations in the lung did not correlate with the amount of HCMV-DNA or the number of HCMV-positive cells detected in the biopsy. An increase of HLA-class II antigen and of ICAM-1 expression on the alveolar epithelium, as well as presence of activated CD8+ or CD4+ lymphocytes infiltrating only HCMV-positive lung biopsies revealed T cell-mediated immune reactions to be involved in the pathogenesis of IP. Since all analyzed patients presented with severe acute or extensive chronic graft-versus-host disease (GvHD), but only those with pulmonary HCMV infection developed IP, dissemination of HCMV appears to be the primary requirement for the initiation of IP. GvHD, however, may interfere with normal control of subsequent antiviral immune response and, thus, provoke the immunopathology of IP.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8577311     DOI: 10.1007/bf00224347

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  41 in total

1.  Analysis by sequential immunoprecipitations of the specificities of the monoclonal antibodies TU22,34,35,36,37,39,43,58 and YD1/63.HLK directed against human HLA class II antigens.

Authors:  A Ziegler; J Heinig; C Müller; H Götz; F P Thinnes; B Uchańska-Ziegler; P Wernet
Journal:  Immunobiology       Date:  1986-03       Impact factor: 3.144

Review 2.  Human marrow transplantation: an immunological perspective.

Authors:  P J Martin; J A Hansen; R Storb; E D Thomas
Journal:  Adv Immunol       Date:  1987       Impact factor: 3.543

3.  Polymerase chain reaction to evaluate antiviral therapy for cytomegalovirus disease.

Authors:  H Einsele; G Ehninger; M Steidle; A Vallbracht; M Müller; H Schmidt; J G Saal; H D Waller; C A Müller
Journal:  Lancet       Date:  1991-11-09       Impact factor: 79.321

4.  A small polypeptide different from beta2-microglobin associated with a human cell surface antigen.

Authors:  A Ziegler; C Milstein
Journal:  Nature       Date:  1979-05-17       Impact factor: 49.962

Review 5.  Pathogenesis of GVHD: role of herpes viruses.

Authors:  A L Appleton; L Sviland
Journal:  Bone Marrow Transplant       Date:  1993-05       Impact factor: 5.483

6.  The relation of viral replication to interstitial pneumonitis in murine cytomegalovirus lung infection.

Authors:  J D Shanley; E L Pesanti
Journal:  J Infect Dis       Date:  1985-03       Impact factor: 5.226

7.  Risk factors for cytomegalovirus infection after human marrow transplantation.

Authors:  J D Meyers; N Flournoy; E D Thomas
Journal:  J Infect Dis       Date:  1986-03       Impact factor: 5.226

8.  Immunohistological skin alterations in allogeneic bone marrow transplantation.

Authors:  C Müller; P Ostendorf; P Wernet; K Schüch; H Wahl; H D Waller
Journal:  Klin Wochenschr       Date:  1984-07-16

9.  Rapid diagnosis of cytomegalovirus pneumonia in marrow transplant recipients by bronchoalveolar lavage using the polymerase chain reaction, virus culture, and the direct immunostaining of alveolar cells.

Authors:  G Cathomas; P Morris; K Pekle; I Cunningham; D Emanuel
Journal:  Blood       Date:  1993-04-01       Impact factor: 22.113

Review 10.  The lung as a critical organ in marrow transplantation.

Authors:  K Quabeck
Journal:  Bone Marrow Transplant       Date:  1994       Impact factor: 5.483

View more
  4 in total

Review 1.  Management of cytomegalovirus infection after solid-organ or stem-cell transplantation. Current guidelines and future prospects.

Authors:  H Hebart; L Kanz; G Jahn; H Einsele
Journal:  Drugs       Date:  1998-01       Impact factor: 9.546

2.  Diagnostic implications of human cytomegalovirus immediate early-1 and pp67 mRNA detection in whole-blood samples from liver transplant patients using nucleic acid sequence-based amplification.

Authors:  M J Blok; I Lautenschlager; V J Goossens; J M Middeldorp; C Vink; K Höckerstedt; C A Bruggeman
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

3.  Modulation of RANTES production by human cytomegalovirus infection of fibroblasts.

Authors:  S Michelson; P Dal Monte; D Zipeto; B Bodaghi; L Laurent; E Oberlin; F Arenzana-Seisdedos; J L Virelizier; M P Landini
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

Review 4.  The multifaceted aspects of interstitial lung disease in rheumatoid arthritis.

Authors:  Lorenzo Cavagna; Sara Monti; Vittorio Grosso; Nicola Boffini; Eva Scorletti; Gloria Crepaldi; Roberto Caporali
Journal:  Biomed Res Int       Date:  2013-09-25       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.